Evaluation of Sexual Function in Women with Overactive Bladder Syndrome

Şen, İ̇lker; Onaran, Metin; Tan, Mustafa; Acar, Cenk; Çamtosun, Ahmet; Sözen, Sinan; Bozkırlı, İbrahim

doi:10.1159/000098066

Cited by 22 publications

(13 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, we cannot support the findings by Ghielmetti et al [4] or David-Montefiore et al [23] that prolapse operations, particularly posterior re- pair, deteriorate sexual function, or that incontinence procedures negatively affect sexual function. Our findings correlate to the findings by Marszalek et al [16] and Sen et al [17]. A limitation of our study is the small number of sexually active patients in the concomitant operation subgroup.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Sexual Impairment in Women Undergoing Laparoscopic Surgery for Genital Prolapse: A Hospital-Based Cohort Study

Banerjee

Sachse²,

Hellmich³

et al. 2010

Urol Int

View full text Add to dashboard Cite

Introduction: No data regarding sexuality following laparoscopic prolapse surgery are available to date. Our hypothesis is that laparoscopic sacropexy does not influence sexuality negatively, whereas concomitant (vaginal) surgery negatively influences sexuality. Methods: Participants were 132 patients who underwent laparoscopic sacropexy. We compared pre- and postoperative sexual scores by 2 validated questionnaires. Results: The response rate was 84% (111/132). No change in sexual activity was reported after surgery. In the sexually active group (56.8%; 63/111) the impairment of sexuality was significantly reduced in all age groups independently of concomitant vaginal surgery. In the sexually inactive group, only 4.3% (2/48) were inactive because of vaginal symptoms before operation. After the operation these patients stayed inactive; however, 1 reported reasons unrelated to prolapse. Conclusions: Laparoscopic prolapse surgery reduces sexual impairment in sexually active patients. There appears to be no benefit for patients who are not sexually active for reasons related to the prolapse. Concomitant surgery does not affect sexual activity.

show abstract

Section: Discussionsupporting

confidence: 91%

“…To date, little is known about the impact of prolapse and urinary incontinence surgery on the female sexual life [16,17], and no data about laparoscopic prolapse sur- Values denote means with SD in parentheses, or numbers with 95% CI in parentheses. OP = Operation.…”

Section: Discussionmentioning

confidence: 99%

Sexual Impairment in Women Undergoing Laparoscopic Surgery for Genital Prolapse: A Hospital-Based Cohort Study

Banerjee

Sachse²,

Hellmich³

et al. 2010

Urol Int

View full text Add to dashboard Cite

show abstract

“…A number of studies have demonstrated a strong association between pelvic floor disorders, lower urinary tract symptoms, overactive bladder with or without urinary incontinence, and FSD [7–14]. The prevalence of FSD in sexual active women attending a urogynecologic outpatient clinic ranges from 48% to 64% [15,16], which is higher than the aforementioned 43% in the general population.…”

Section: Introductionmentioning

confidence: 98%

The Place of Female Sexual Dysfunction in the Urological Practice: Results of a Dutch Survey

Bekker

Beck

Putter

et al. 2009

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Female sexual dysfunction (FSD) is a highly prevalent and often underestimated problem. There is a strong association between urological complaints and FSD. Aims The purpose of this survey was to evaluate how Dutch urologists address FSD in their daily practice. Methods We performed an anonymous survey study. A 17-item anonymous questionnaire was mailed to all 405 registered members of the Dutch Urology Association (urologists and residents in urology). Main Outcome Measures The survey results. Results One hundred eighty-six complete surveys of eligible respondents were returned (45.9% response rate). Ten respondents (5.5%) stated that they ask each female patient for sexual function; 87.1% stated that they ask for sexual function when a patient complains about lower abdominal pain (87.2%), incontinence (75.8%), urgency or frequency (70.5%), or urinary tract infections (65.8%). Many respondents (40.3%) do not think that FSD is meaningful in a urological practice. The majority of respondents (91%) underestimate the frequency of FSD in a urological clinic. Respondents who believe the frequency of FSD to be at least 30% tend to ask more often for sexual function than the rest of the group (P = 0.08). Conclusion Overall, many urologists do not consistently ask each female patient for sexual function and underestimate the prevalence of FSD. For the majority of the members of the Dutch Urological Association, FSD is not part of routine urological practice. There is, therefore, a need for better implementation of education and training at both undergraduate and postgraduate levels.

show abstract

“…The prevalence of female sexual dysfunction (FSD) in menopausal women differs according to several factors; in the longest population study, which was held in Australia [7], the prevalence of FSD ranged from 42% to 88%.…”

Section: Introductionmentioning

confidence: 99%

Impact of Sacral Neuromodulation on Female Sexual Function and His Correlation with Clinical Outcome and Quality of Life Indexes: A Monocentric Experience

Signorello

Seitz

Berner

et al. 2011

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Lower urinary tract symptoms (LUTS) have a profound impact on physical, social, and sexual well-being. Sacral neuromodulation (SNM) may have a positive effect on sexuality, though few studies have so far evaluated its impact on female sexual function. Aim To prospectively assess changes in sexual function, clinical outcome and quality of life after SNM in female patients with overactive bladder (OAB) and their possible correlation with improvement in urinary symptoms and quality of life indexes. Main Outcome Measures Correlations between differences in Female Sexual Function Index (FSFI) scores and in clinical outcome and correlations between differences in FSFI, SF36, and IQoL scores were evaluated by Spearman’s coefficient. Comparison between preoperative, midterm follow-up (MFU), and last follow-up (FFU) visits were performed by generalized linear model (GLM) for repeated measurements. Methods Between May 2003 and December 2008, 30 consecutive female patients (median age 53 years, range 35–79) with OAB underwent the two-stage procedure of SNM. Only 16 (53%) patients were considered eligible; these completed a bladder diary, the FSFI, the Status of Health questionnaire (SF36) and the Incontinence Quality of Life Index (IQoL) before implantation and on follow-up examinations. Results The results were analyzed before implantation, on MFU (median MFU 22.5 months) and on FFU (median FFU period 36.3 months). Regarding sexuality, the mean improvement in the total FSFI score was 27.9% on MFU and 29.3% on FFU. Only four patients (25%) showed a >50% improvement in global FSFI score on MFU, and 3 (25%) on FFU. A significant correlation was found between clinical improvement and improvement in sexual function. No significant correlation was found between differences in FSFI and quality of life indexes (IQoL and SF36). Conclusion Our results demonstrate that improvement in the quality of sexual function in female patients with OAB correlates with improvement in urinary symptoms.

show abstract

Evaluation of Sexual Function in Women with Overactive Bladder Syndrome

Cited by 22 publications

References 30 publications

Sexual Impairment in Women Undergoing Laparoscopic Surgery for Genital Prolapse: A Hospital-Based Cohort Study

Sexual Impairment in Women Undergoing Laparoscopic Surgery for Genital Prolapse: A Hospital-Based Cohort Study

The Place of Female Sexual Dysfunction in the Urological Practice: Results of a Dutch Survey

Impact of Sacral Neuromodulation on Female Sexual Function and His Correlation with Clinical Outcome and Quality of Life Indexes: A Monocentric Experience

Contact Info

Product

Resources

About